International Cannabis Weekly: 144

• US hemp farmers to be included in the COVID-19 relief loan programme.
• FDA sends warning letter to British CBD firm over coronavirus claims.
• Online cannabis orders grew fourfold in Canada after COVID-19 restrictions.
• US senators request small cannabis firms be included in COVID-19 relief.
• Israel’s illicit cannabis sellers say COVID-19 has boosted the black market.
• Medical cannabis registrations spike as adult-use stores shut in Massachusetts.

• Prohibition Partners LIVE launches super early bird tickets.
• Lebanese parliament passes medical and industrial cannabis legalisation bill.
• Mexico’s Supreme Court extends cannabis legalisation deadline to 15 December.

• Iceland amends narcotics laws to allow imports of hemp seeds.
• German wholesalers of Dutch cannabis under pressure as competition grows.
• Danish Medical Agency says it will ‘gradually resume’ on-site cannabis inspections.
• Scottish group progress plan for domestic cultivation.

• Canada’s pre-pandemic cannabis sales fell slightly in February.
• Ontario regulator resumes issuance of new cannabis store authorisations.
• Some Canadian cannabis firms report record revenues for the 4/20 weekend.

• California establishes US$30 million business programme to support social equity.
• Iowa issues the state’s first hemp licences and seed permits.
• Kansas representative says legal cannabis could help rectify budget shortfalls.
• Colorado honours the passing of Charlotte Figi, naming 7 April ‘Charlotte Figi Day’.
• Alaska implements plan to allow cannabis drive-through and curbside pickup sales.
• Michigan judge invalidates 15 cannabis firm licences after meeting rules broken.
• Poll finds a majority of US adults believe cannabis reform has been a success.

• THC Global’s first Australian cannabis medicines to be available from 20 May.
• New Zealand’s medical cannabis charity joins the Health Not Handcuffs campaign.
• A quarter of Australians with IBD report using cannabis to manage symptoms.

• Supply issues hinder Uruguay’s recreational cannabis market growth.
• Khiron enters medical cannabis distribution deal with healthcare retailer Locatel.
• Brains Bioceuticals to provide API for registered medical cannabis products in Brazil.

• Cannabis operations continue in South Africa despite Canopy Growth exit.
• Lesotho’s MG Health lays off 72 workers citing cash flow challenges.
• IM Cannabis secures US$57.2 million deal with Israel’s largest drugstore chain.

• New study set to examine the anti-inflammatory action of CBD on COVID-19 patients.
• Review finds cannabinoids ‘may reduce pain and spasticity’ in spinal injuries.
• Zelira Therapeutics finds cannabinoid extracts useful in combating chronic insomnia.

• Champignon Brands acquires Canada’s only approved psychedelic medicine clinic.
  
• Peter Thiel backs ATAI Life Sciences in latest funding round, worth US$24 million.
• California psilocybin legalisation campaign ends after signature deadline passes.
• Poll finds Washington D.C. voters would likely vote to decriminalise psychedelics.
• MindMed announces plans to develop a ‘neutraliser’ for psychedelic trips.

Prohibition Partners is proud to launch The Oceania Cannabis Report: Second Edition. The report contains expert analysis on the latest industry developments across Australia, New Zealand and the surrounding islands, which is set to be worth $US1.55 billion by 2024.

Download your free copy of the report, here.